Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Francis deSouza, Lyn Griffiths


Francis de Souza has been named president of Illumina. In his new role, de Souza will report to CEO Jay Flatley, and will lead the San Diego company's business units. He will also join Illumina's executive management team.

Illumina announced a business reorganization last month that was accompanied by changes in managerial duties, and included the splitting of the roles of president and CEO (BAN 10/22/2013).

DeSouza will join Illumina in December. He currently serves as president of products and services at Symantec, which he joined after Symantec acquired Imlogic, a company he co-founded and led as CEO. DeSouza was also the co-founder and CEO of Flash Communications, which Microsoft acquired in 1998. Following that acquisition, deSouza worked at Microsoft and was responsible for the development of the company's enterprise real-time collaboration offerings.

DeSouza holds MSc and BSc degrees in electrical engineering and computer science from the Massachusetts Institute of Technology.

Lyn Griffiths has been appointed executive director of Queensland University of Technology's Institute of Health and Biomedical Innovation.

Griffiths joins QUT from Griffith University, where she was was head of the School of Medical Science, and then dean research and director of the Griffith Health Institute.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.